Rationale and organizational aspects
1) Primary angioplasty vs thrombolysis: an overview of randomized trials and registry data (Boersma E)
2) Which patient should be transferred for primary PCI? (Kristensen D)
3) Pharmacological facilitation in primary angioplasty: myth or reality? (G De Luca)
4) How to organize networks for invasive treatment of STEMI:
4.a Krakow Experience (Dudek D)
4.b Zwolle Experience (van’t Hof AWJ – de Boer MJ)
4.c Linkoping Experience (Janzon M)
4.d Experience in the USA (Grines C and Cox D)
4.e Experience in Asia (Park SJ)
5) Failed thrombolysis: rescue angioplasty or conservative therapy? (Ellis S)
6) Primary PCI in cardiogenic shock and out-of-hospital cardiac arrest (M Noc)
Adjunctive pharmacotherapy:
7) Oral antiplatelet therapy (Montalescot G)
8) Gp IIb-IIIa inhibitors (Moliterno D)
9) Anticoagulation therapy (DeLuca)
Technical aspects:
10) Balloon angioplasty or BMS? (De Luca G)
11) Drug-Eluting Stent: Weighing costs and benefits (Kastrati A)
12) Mechanical prevention of distal embolization: Rationale and trial results (De Luca G)
13) Distal protection devices: Tips and Tricks (Dangas G)
14) Thrombectomy devices: Tips and tricks (Antoniucci D)
15) Proximal devices: Tips and tricks (KT Koch)
16) Haemodynamic support in high-risk patients (Henriques J)
17) Limitation of infarct size: Adjunctive mechanical devices (Dixon S)
18) Radial Approach (Amoroso G)
19) OCT, IVUS and Angioscopy (De Luca G)
Redefining the success of mechanical reperfusion:
20) ST-segment resolution (De Luca G)
21) Myocardial Blush Grade and cTFC (Lansky A)
22) Doppler flow-wire (Jan Piek)
23) MRI (Iliceto S)
24) Contrast echocardiography (Ito H)
25) Nuclear techniques (Sciagra R)
Special Issues:
26) Bleeding complications: prognostic implications, prevention and management (Nikolsky E and Mehran R)
27) Contrast Induced Nephropathy: prognostic implications, prevention and management (Bartorelli A)
A glimpse into the future:
28) Myocardial regeneration (Zijlstra F)
29) Early discharge after primary PCI (Laarman, Dirksen)
Guidelines
30) ACC/AHA and ESC guidelines (De Luca G)
1) Primary angioplasty vs thrombolysis: an overview of randomized trials and registry data (Boersma E)
2) Which patient should be transferred for primary PCI? (Kristensen D)
3) Pharmacological facilitation in primary angioplasty: myth or reality? (G De Luca)
4) How to organize networks for invasive treatment of STEMI:
4.a Krakow Experience (Dudek D)
4.b Zwolle Experience (van’t Hof AWJ – de Boer MJ)
4.c Linkoping Experience (Janzon M)
4.d Experience in the USA (Grines C and Cox D)
4.e Experience in Asia (Park SJ)
5) Failed thrombolysis: rescue angioplasty or conservative therapy? (Ellis S)
6) Primary PCI in cardiogenic shock and out-of-hospital cardiac arrest (M Noc)
Adjunctive pharmacotherapy:
7) Oral antiplatelet therapy (Montalescot G)
8) Gp IIb-IIIa inhibitors (Moliterno D)
9) Anticoagulation therapy (DeLuca)
Technical aspects:
10) Balloon angioplasty or BMS? (De Luca G)
11) Drug-Eluting Stent: Weighing costs and benefits (Kastrati A)
12) Mechanical prevention of distal embolization: Rationale and trial results (De Luca G)
13) Distal protection devices: Tips and Tricks (Dangas G)
14) Thrombectomy devices: Tips and tricks (Antoniucci D)
15) Proximal devices: Tips and tricks (KT Koch)
16) Haemodynamic support in high-risk patients (Henriques J)
17) Limitation of infarct size: Adjunctive mechanical devices (Dixon S)
18) Radial Approach (Amoroso G)
19) OCT, IVUS and Angioscopy (De Luca G)
Redefining the success of mechanical reperfusion:
20) ST-segment resolution (De Luca G)
21) Myocardial Blush Grade and cTFC (Lansky A)
22) Doppler flow-wire (Jan Piek)
23) MRI (Iliceto S)
24) Contrast echocardiography (Ito H)
25) Nuclear techniques (Sciagra R)
Special Issues:
26) Bleeding complications: prognostic implications, prevention and management (Nikolsky E and Mehran R)
27) Contrast Induced Nephropathy: prognostic implications, prevention and management (Bartorelli A)
A glimpse into the future:
28) Myocardial regeneration (Zijlstra F)
29) Early discharge after primary PCI (Laarman, Dirksen)
Guidelines
30) ACC/AHA and ESC guidelines (De Luca G)
Giuseppe De Luca
Assistant Professor of Cardiology, Chief Interventional Cardiology, Ospedale “Maggiore della Carità” Eastern Piedmont University, Novara, Italy
Alexandra Lansky
Associate Professor of Clinical Medicine Director, Clinical Services, Center for Interventional Vascular Therapy Columbia University Medical Center Joint Chief Scientific Officer, Clinical Trial Center and Director, Women's Cardiovascular Health Initiative Cardiovascular Research Foundation New York, NY 10022
Assistant Professor of Cardiology, Chief Interventional Cardiology, Ospedale “Maggiore della Carità” Eastern Piedmont University, Novara, Italy
Alexandra Lansky
Associate Professor of Clinical Medicine Director, Clinical Services, Center for Interventional Vascular Therapy Columbia University Medical Center Joint Chief Scientific Officer, Clinical Trial Center and Director, Women's Cardiovascular Health Initiative Cardiovascular Research Foundation New York, NY 10022
